| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |